Multimodal artificial intelligence in glioma management: integrating neuroimaging and hematologic biomarkers for precision oncology
{{output}}
Background: Gliomas are biologically heterogeneous primary brain tumors that remain challenging to diagnose, prognosticate, and monitor noninvasively, owing to marked intratumoral heterogeneity, treatment-related imaging changes,... ...
